Education
About Us
Working with TipRanks
Follow Us
Ind-Swift Ltd. (IN:INDSWFTLTD)
:INDSWFTLTD
INDSWFTLTD Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹12.00 - ₹34.49
Previous CloseN/A
Volume124.27K
Average Volume (3M)63.66K
Market Cap
₹867.18M
Enterprise Value₹10.85B
Total Cash (Recent Filing)₹688.45M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)0.3
Beta1.40
Next Earnings
Aug 07, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 21, 2011Dividend YieldN/A
Share Statistics
EPS (TTM)47.37
Shares Outstanding54,164,654
10 Day Avg. Volume9,581
30 Day Avg. Volume63,657
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ind-Swift Ltd. News
INDSWFTLTD FAQ
What was Ind-Swift Ltd.’s price range in the past 12 months?
Ind-Swift Ltd. lowest stock price was ₹12.00 and its highest was ₹34.49 in the past 12 months.
What is Ind-Swift Ltd.’s market cap?
Ind-Swift Ltd.’s market cap is ₹867.18M.
When is Ind-Swift Ltd.’s upcoming earnings report date?
Ind-Swift Ltd.’s upcoming earnings report date is Aug 07, 2025 which is 2 days ago.
How were Ind-Swift Ltd.’s earnings last quarter?
Ind-Swift Ltd. released its earnings results on Jun 25, 2025. The company reported ₹47.37 earnings per share for the quarter, beating the consensus estimate of N/A by ₹47.37.
Is Ind-Swift Ltd. overvalued?
According to Wall Street analysts Ind-Swift Ltd.’s price is currently Overvalued.
Does Ind-Swift Ltd. pay dividends?
Ind-Swift Ltd. pays a Annually dividend of ₹0.4 which represents an annual dividend yield of N/A. See more information on Ind-Swift Ltd. dividends here
What is Ind-Swift Ltd.’s EPS estimate?
Ind-Swift Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ind-Swift Ltd. have?
Ind-Swift Ltd. has 54,164,654 shares outstanding.
What happened to Ind-Swift Ltd.’s price movement after its last earnings report?
Ind-Swift Ltd. reported an EPS of ₹47.37 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.31%.
Which hedge fund is a major shareholder of Ind-Swift Ltd.?
Currently, no hedge funds are holding shares in IN:INDSWFTLTD
Company Description
Ind-Swift Ltd.
Ind-Swift Limited manufactures and sells pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names; gynecology, pediatrics, dermatology, and GP under the Anin, Suprox, Cozy, Distone, and Oliade name; and antibiotic, anti-cold, nutraceuticals, anti-diarrheal, anti-malarial, anti-depressants, cardiology, diabetology, neurology, and oncology. The company also provides contract research and manufacturing services. It serves government dispensaries, doctors, and hospitals through retailers, stockists, and carrying and forwarding channels. The company exports its products to approximately 50 countries. Ind-Swift Limited was founded in 1983 and is based in Chandigarh, India.
Technical Analysis
Balaxi Pharmaceuticals Limited
―
Biofil Chemicals & Pharmaceuticals Ltd.
―
Ind-Swift Laboratories Ltd.
―
Krebs Biochemicals & Industries Ltd.
―
Lasa Supergenerics Ltd.
―